Literature DB >> 6155160

Towards tumor therapy with interferons, part II. Interferons: in vivo effects.

M Krim.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6155160

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  9 in total

Review 1.  Interferons 1992. How much of the promise has been realised?

Authors:  M A Volz; C H Kirkpatrick
Journal:  Drugs       Date:  1992-03       Impact factor: 9.546

2.  Treatment with human recombinant leukocyte interferons inhibits in vitro invasive ability of human lung carcinoma cells.

Authors:  T J Ravine; N Ledinko
Journal:  Clin Exp Metastasis       Date:  1986 Jul-Sep       Impact factor: 5.150

3.  Activation of 2',5'-oligoadenylate synthetase and B-2 microglobulin in cancer patients treated with partially pure gamma interferon: dependence of biological effect on administration route.

Authors:  M G Rosenblum; A Riso; J U Gutterman
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

Review 4.  Differences between human alpha (leukocyte) and beta (fibroblast) interferons.

Authors:  T G Hayes
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

Review 5.  The interferon renaissance: molecular aspects of induction and action.

Authors:  J Gordon; M A Minks
Journal:  Microbiol Rev       Date:  1981-06

6.  Pharmacokinetics and biological activity in subcutaneous long-term administration of recombinant interferon-gamma in cancer patients.

Authors:  W Digel; G Zahn; G Heinzel; F Porzsolt
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

7.  Phase II trial of recombinant leukocyte A interferon in advanced malignant melanoma.

Authors:  U Elsässer-Beile; N Drees; H A Neumann; E Schöpf
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

8.  The treatment of cancer patients with human lymphoblastoid interferon. A comparison of two routes of administration.

Authors:  J A Knost; S A Sherwin; P G Abrams; J J Ochs; K A Foon; R Williams; R Tuttle; R K Oldham
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

9.  Enhancement and suppression of DTH reactivity to Rauscher murine leukaemia virus induced tumour cell lines.

Authors:  A C Knulst; D Berends; C Bazuin; H C van Rooij; N J de Both; R Benner
Journal:  Br J Cancer       Date:  1989-09       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.